Dextenza 0.4 MG insert 10S
Ended Awarded
- Contract number
- SPE2DB25FSTD0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,424
Award facts
- Contract value 100% obligated
- $14,423.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $14,423.60 by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Dextenza 0.4 mg inserts (10-pack). The contract is a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of October 17, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a single-award contract valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products to support Department of Defense medical facility needs worldwide.
Dextenza is a prescription ophthalmic medication commonly used in post-operative eye care settings. As a primary supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its status as a woman-owned small business to deliver branded and generic pharmaceuticals, biologics, and medical consumables directly to military healthcare facilities. The company has demonstrated consistent success in securing delivery orders across diverse product categories ranging from specialty medications to vaccines, establishing itself as a critical resource for DLA pharmaceutical procurement operations.
Quick answers
Who was awarded contract SPE2DB25FSTD0?
SPE2DB25FSTD0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FSTD0 worth?
The government has obligated $14,424 on SPE2DB25FSTD0.
Is contract SPE2DB25FSTD0 an order under another contract?
Yes. SPE2DB25FSTD0 is a delivery order under SPE2DB22D9304, an indefinite delivery contract.
Was contract SPE2DB25FSTD0 competed?
The extent of competition for SPE2DB25FSTD0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award